Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Klaus K Herfarth

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6325-4193; OpenAlex author ID A5070621357. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2020: 2 papers · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 8

  1. Carbon ion radiotherapy for non-metastatic pancreatic cancer: final results of the prospective phase 2 PACK-study (NCT04194268). Last author DOI 10.1016/j.radonc.2026.111836↗
  2. Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro. Co-author DOI 10.3390/cancers16081497↗
  3. Carbon-ion radiotherapy (CIRT) as treatment of pancreatic cancer at HIT: initial radiation plan analysis of the prospective phase II PACK-study. Co-author DOI 10.1016/j.radonc.2023.109872↗
  4. Carbon ion radiotherapy as definitive treatment in locally recurrent pancreatic cancer. Co-author DOI 10.1007/s00066-021-01827-9↗
  5. Effectiveness of Carbon Ion Radiation in Locally Advanced Pancreatic Cancer. Last author DOI 10.3389/fonc.2021.708884↗
  6. Impact of FAPI-PET/CT on Target Volume Definition in Radiation Therapy of Locally Recurrent Pancreatic Cancer. Co-author DOI 10.3390/cancers13040796↗
  7. Carbon ion radiotherapy in pancreatic cancer: A review of clinical data. Co-author DOI 10.1016/j.radonc.2020.05.012↗
  8. Carbon ion radiotherapy as definitive treatment in non-metastasized pancreatic cancer: study protocol of the prospective phase II PACK-study. Last author DOI 10.1186/s12885-020-07434-8↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jakob Liermann · 8 shared papers, 2020–2026 · strength 1.33
  2. Jürgen Debus · 7 shared papers, 2020–2026 · strength 1.15
  3. Patrick Naumann · 6 shared papers, 2020–2026 · strength 0.94
  4. Andrea Mairani · 3 shared papers, 2023–2026 · strength 0.61
  5. Filipa Baltazar · 2 shared papers, 2023–2026 · strength 0.41
  6. Manuel Röhrich · 2 shared papers, 2021–2026 · strength 0.34
  7. Edgar Ben‐Josef · 2 shared papers, 2021–2022 · strength 0.30
  8. Christoph Michalski · 1 shared paper, 2026 · strength 0.23
  9. Semi Harrabi · 1 shared paper, 2026 · strength 0.23
  10. Christoph Springfeld · 1 shared paper, 2026 · strength 0.23
  11. Ivana Đokić · 1 shared paper, 2024 · strength 0.21
  12. Bahar Cepni · 1 shared paper, 2024 · strength 0.21
  13. Juergen Debus · 1 shared paper, 2023 · strength 0.18
  14. Makoto Shinoto · 1 shared paper, 2020 · strength 0.13
  15. Frederik Lars Giesel · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.